IBDEI0DH ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6185,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,6185,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,6186,0)
 ;;=E16.2^^30^388^29
 ;;^UTILITY(U,$J,358.3,6186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6186,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,6186,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,6186,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,6187,0)
 ;;=E20.0^^30^388^34
 ;;^UTILITY(U,$J,358.3,6187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6187,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,6187,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,6187,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,6188,0)
 ;;=E20.9^^30^388^30
 ;;^UTILITY(U,$J,358.3,6188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6188,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,6188,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,6188,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,6189,0)
 ;;=E23.0^^30^388^31
 ;;^UTILITY(U,$J,358.3,6189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6189,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,6189,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,6189,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,6190,0)
 ;;=E27.1^^30^388^51
 ;;^UTILITY(U,$J,358.3,6190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6190,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,6190,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,6190,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,6191,0)
 ;;=E27.2^^30^388^1
 ;;^UTILITY(U,$J,358.3,6191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6191,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,6191,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,6191,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,6192,0)
 ;;=E27.3^^30^388^23
 ;;^UTILITY(U,$J,358.3,6192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6192,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,6192,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,6192,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,6193,0)
 ;;=E29.1^^30^388^52
 ;;^UTILITY(U,$J,358.3,6193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6193,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,6193,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,6193,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,6194,0)
 ;;=E55.9^^30^388^59
 ;;^UTILITY(U,$J,358.3,6194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6194,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,6194,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,6194,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,6195,0)
 ;;=E66.01^^30^388^38
 ;;^UTILITY(U,$J,358.3,6195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6195,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,6195,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,6195,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,6196,0)
 ;;=E66.8^^30^388^42
 ;;^UTILITY(U,$J,358.3,6196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6196,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,6196,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,6196,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,6197,0)
 ;;=E66.9^^30^388^43
 ;;^UTILITY(U,$J,358.3,6197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6197,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,6197,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,6197,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,6198,0)
 ;;=E74.39^^30^388^35
 ;;^UTILITY(U,$J,358.3,6198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6198,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,6198,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,6198,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,6199,0)
 ;;=E83.30^^30^388^46
 ;;^UTILITY(U,$J,358.3,6199,1,0)
 ;;=^358.31IA^4^2
